Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,826.00    -2.00 (-0.07%)
Bid:
2,824.00
Ask:
2,826.00
Spread: 2.00 (0.071%)
Market Cap: £6.72b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Interim Management Statement

9 May 2024 07:00

RNS Number : 6956N
IMI PLC
09 May 2024
 

9 May 2024

 

First quarter performance in line with expectations

Full year guidance reconfirmed

 

IMI, the specialist engineering company, issues the following Interim Management Statement which covers results for the first quarter from 1 January to 31 March 2024.

 

Roy Twite, Chief Executive, commented:

 

"We were pleased to deliver another solid quarter of organic growth, up 4% in the first quarter, in mixed markets and against a strong comparator. Based on current market conditions, our guidance remains unchanged and we still expect that 2024 full year adjusted EPS will be between 120p and 126p".

 

Encouraging first quarter performance

 

Group organic revenue was up 4% compared to the same period last year. Adjusted revenue was flat, reflecting the foreign currency movements seen in the first quarter.

 

Our restructuring programme remains on track to deliver £15m of incremental benefits for the full year and £7m in 2025, with no changes to expected delivery costs.

 

Sector performance in line with expectations

 

Automation

 

Automation (62% of 2023 sales) delivered a strong performance, with revenue up 12% organically.

 

Process Automation (37% of 2023 sales) had an excellent quarter as we saw continued momentum across our energy end markets and further progress in the Aftermarket. Organic revenue was 27% higher than the prior period. Orders were down 3% organically, due to the one-off £26m Marine order in the prior period.

 

Industrial Automation (25% of 2023 sales) organic revenue was 5% lower than the same period last year, reflecting the strong first quarter comparator and lower industrial activity in Europe and the Americas.

 

Life Technology

 

As expected, Life Technology (38% of 2023 sales) revenue was down 6% organically in the first quarter versus the same period last year. We continue to expect the platform to be broadly flat in the full year.

 

Climate Control (18% of 2023 sales) organic revenue was 4% lower than the prior period, as expected given the 12% organic growth delivered in the first quarter of 2023. Whilst dynamics in the European construction market did impact sales in the quarter, underlying demand for our energy efficient products remains strong. 

 

Life Science and Fluid Control (12% of 2023 sales) organic revenue was down 22%, as expected given the tough first quarter comparator and continued softness experienced across the global life sciences device market.

 

Transport (8% of 2023 sales) organic revenue grew 19% in the first quarter. We continue to benefit from strong growth in Asia and our new product launches, supported by favourable regulatory tailwinds.

 

Disposal of non-core business

 

On 25 April 2024 the Group disposed of Industrie Mécanique pour les Fluides, a non-core subsidiary within the Life Science & Fluid Control sector, for an enterprise value of €19m. The business contributed around 1% of sales and operating profit in 2023.

 

Exchange rates

 

If exchange rates as at 26 April 2024 of US$1.25 and €1.17 remain constant for the remainder of the year, we continue to expect a headwind on both revenue and adjusted operating profit of 2% in the 2024 full year when compared to 2023.

 

Outlook

 

Based on current market conditions, our guidance for 2024 full year adjusted EPS is unchanged at 120p to 126p.

 

Interim results

 

IMI will issue its interim results announcement in respect of the six months ending 30 June 2024 on 26 July 2024.

 

Enquiries

 

Luke Grant

IMI

Tel: +44 (0)7866 148 374

Matt Denham

Headland

Tel: +44 (0)7551 825 496

 

A conference call for analysts and investors will be held at 08:00 BST today to discuss this statement. To access the call, please register using the link:

 

https://www.netroadshow.com/events/login?show=ed69d8ce&confId=64057

 

Notes

 

IMI plc is a FTSE100 global specialist engineering company that designs, manufactures and services highly engineered products to control the precise movement of fluids. Its innovative motion and flow control technologies, built around valves and actuators, enable vital sectors to become safer, more sustainable and more productive. IMI combines world class applications engineering expertise with a continued focus on customer satisfaction, market-led innovation and complexity reduction to solve its customers most acute engineering problems. IMI employs approximately 10,000 people, has manufacturing facilities in 18 countries and operates a global service network. The Company is listed on the London Stock Exchange. Further information is available at www.imiplc.com.

 

References to adjusted figures reflect figures as reported to management and do not include the impact of adjusting items. References to organic changes are on a constant currency basis and exclude disposals and acquisitions.

 

IMI plc is registered in England No. 714275. Its legal entity identifier ('LEI') number is 2138002W9Q21PF751R30.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBRGDUGSGDGSI
Date   Source Headline
1st Apr 20209:56 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSCoronavirus update
26th Mar 20203:58 pmRNSHolding(s) in Company
18th Mar 20204:56 pmRNSDirector/PDMR Shareholding
17th Mar 20204:37 pmRNSDirector/PDMR Shareholding
12th Mar 202010:52 amRNSDirector/PDMR Shareholding
11th Mar 202012:18 pmRNSDirector/PDMR Shareholding
2nd Mar 20203:10 pmRNSTotal Voting Rights
28th Feb 20207:00 amRNSPreliminary results, year ended 31 December 2019
12th Feb 20203:07 pmRNSDirector/PDMR Shareholding
3rd Feb 202010:55 amRNSTotal Voting Rights
15th Jan 202012:15 pmRNSDirector/PDMR Shareholding
13th Jan 20203:31 pmRNSHolding(s) in Company
3rd Jan 202011:54 amRNSBlock listing Interim Review
2nd Jan 20202:04 pmRNSTotal Voting Rights
11th Dec 20192:40 pmRNSDirector/PDMR Shareholding
2nd Dec 201910:20 amRNSTotal Voting Rights
27th Nov 20199:00 amRNSNon-executive director changes
21st Nov 20198:10 amRNSDirector/PDMR Shareholding
14th Nov 201910:04 amRNSDirector/PDMR Shareholding
7th Nov 20197:00 amRNSIMS and Strategy Review conclusions
1st Nov 201910:04 amRNSTotal Voting Rights
9th Oct 20192:07 pmRNSDirector/PDMR Shareholding
1st Oct 201910:17 amRNSTotal Voting Rights
23rd Sep 20197:00 amRNSCompletion of PBM acquisition
16th Sep 20193:51 pmRNSDirector/PDMR Shareholding
11th Sep 20191:08 pmRNSDirector/PDMR Shareholding
2nd Sep 201910:18 amRNSTotal Voting Rights
20th Aug 20197:00 amRNSProposed acquisition of PBM for $85m
14th Aug 20191:42 pmRNSDirector/PDMR Shareholding
12th Aug 20193:40 pmRNSNon-executive director change
1st Aug 20194:17 pmRNSTotal Voting Rights
26th Jul 20197:00 amRNSInterim Results, six months ended 30 June 2019
15th Jul 20194:29 pmRNSDirector Declaration
10th Jul 20192:03 pmRNSDirector/PDMR Shareholding
4th Jul 20194:07 pmRNSBlock listing Interim Review
1st Jul 201910:35 amRNSTotal Voting Rights
12th Jun 201912:38 pmRNSDirector/PDMR Shareholding
10th Jun 20193:18 pmRNSDirector/PDMR Shareholding
3rd Jun 201910:24 amRNSTotal Voting Rights
20th May 20193:18 pmRNSDirector/PDMR Shareholding
15th May 201912:14 pmRNSDirector/PDMR Shareholding
9th May 20192:05 pmRNSResult of AGM
9th May 20197:00 amRNSInterim Management Statement
1st May 201910:44 amRNSTotal Voting Rights
12th Apr 20193:17 pmRNSDirector/PDMR Shareholding
10th Apr 20193:50 pmRNSDirector/PDMR Shareholding
5th Apr 20199:07 amRNSDirector/PDMR Shareholding
1st Apr 201911:36 amRNSTotal Voting Rights
29th Mar 20194:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.